Complications of CT-guided percutaneous Argeon-Helium cryoablation in the treatment of malignant liv

来源 :2016第十二届亚太介入放射学大会 | 被引量 : 0次 | 上传用户:wy299
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objectives:To summarize the causes of complications of CT-guided percutaneous Argeon-Helium cryoablation in the treatment of malignant liver tumors,to establish a preventive strategy and investigate its clinical efficacy.
其他文献
We found that the tumor necrosis and shrinkage were obvious after GSMs-TACE treatment for HCC.Moreover,it is uncommon for lymph node metastasis from HCC after GSMs-TACE.
Background & Aims:We conducted this multicenter retrospective study to evaluate the efficacy of sorafenib combined with transarterial chemoembolization(TACE)compared to TACE monotherapy in intermediat
会议
NAF
Objectives: To highlight the variable techniques for treating cavernous aneurysm depending upon its size/shape and clinical presentations.
会议
Objective:To investigate the effectiveness and safety of ozonated saline injected directly into tumor for treatment of VX-2 tumor and to explore the mechanism.
Aims:To assess the efficacy of continued administration of sorafenib for patients with unresectable hepatocellular carcinoma(HCC)treated with local regional therapy(LRT)after a complete response(CR),a
Purpose:To evaluate the performance of quantitative EASL(qEASL),a volumetric enhancement criterion,to assess tumor response and predict overall survival(OS)in patients with hepatocellular carcinoma(HC
Background:The survival benefit of combining sorafenib and transarterial chemoembolization(TACE)therapy compared with sorafenib monotherapy for patients with advanced hepatocellular carcinoma(HCC)and
Objective:To explore the effect of sequential therapy of transcatheter arterial chemoembolization(TACE)followed by percutaneous microwave coagulation therapy(PMCT)intreating early-stageprimary hepatoc
Objectives:To investigate the clinical effects of CT— guided percutaneous Argeon-Helium cryoablation in the treatment of bone metastases.